Universitätsklinik für Viszerale Chirurgie und Medizin

Inselspital Bern

Die Universitätsklinik bietet einen interdisziplinären Service im Bereich der viszeralen Chirurgie und Medizin an. Auf dem Gebiet der hochspezialisierten Medizin werden vorwiegend Patientinnen und Patienten mit Tumorleiden und anderen komplexen Baucherkrankungen betreut.

Zur Webseite des Inselspitals

Geschäftsführender Direktor und Leiter der Chirurgie

Prof. Daniel Candinas

Profil

  • Viszeralchirurgie – Gastroenterologie – Hepatologie
  • Abteilung für Endoskopie
  • Transplantation

Externe Partner

ETH Zurich, Systems Biology and Laboratory of Biological Engineering; Karolinska Institutet, Department of Surgery, Stockholm; University of Geneva, Molecular Biology; University of Neuchâtel, Department of Psychology; Baveno Cooperation (EASL Research Consortium); University Hospital of Bologna, Department of Internal Medicine; University of Freiburg, Germany; Crick Institute London, UK; Harvard Medical School; Institute of Immunology and Department of Pathology University of Cambridge; Kennedy Institute, University of Oxford; Department of Radiology, Jefferson University, USA; Department of Hepatology and Liver Transplantation, Mayo Clinic Rochester, USA; Liver Unit, Hospital Clinic, Barcelona, Spain; SCCS (Swiss Hepatitis C Cohort Study); ELTR (European Liver Transplant Registry); STCS (Swiss Transplant Cohort Study); LITMUS Study, DILI Registry Study (Prospective European Drug-induced liver injury Registry); ERN Rare-Liver (European Reference Network – Rare liver diseases)

Grants

  • SNF: DNA Damage Checkpoint Pathways (Prof. H. Athanassios, CHF 953’302)
  • Gebert Rüf Stiftung: CALDRE – InnoBooster (Dr. F. Baier, CHF 150'000)
  • Innosuisse Schweizerische Agentur für Innovationsförderung:
  • Aquiliv (Prof. D. Keogh-Stroka, CHF 542’695)
  • Digitalisierungskommission der Universität Bern: The CARESCORE (Prof. Beldi, CHF 500'000)
  • Universität Bern MCID Funding Call: MCID- Immune response during liver-stage parasitic infections (MA25_04) (Prof. D. Keogh-Stroka, CHF 160’100)
  • Fondation Aclon: ACLON - Importance and function of PCSK9 in the biliary system. DNA Damage and Origin Firing during Liver Regeneration (Prof. D. Keogh-Stroka, CHF 300’000)
  • Fondation Aclon: ACLON - Rescue of liver regeneration in aged mice and mice with MASH (Prof. H. Athanassios, CHF 200’000)
  • Fondation contre le cancer, Lausanne: Pancreas Tissue Characterization by Müller Matrix Polarimetry for use in Intraoperative Diagnostics (ID) (Prof. D. Candinas, CHF 210’000)
  • SF Board grant: Towards reducing infections after healthcare-associated interventions (Prof. G. Beldi, CHF 750’000)
  • Innosuisse – Suisse Innovation Agency: Caldre: Cholestasis and liver disease resolved (Dr. F. Baier/Prof. D. Keogh-Stroka, CHF 517’000)
  • SNF Starting Grant: Macrophage Aggregation Control against Scarring (MACScar) (Prof. J. Zindel, CHF 1’790’000)
  • SNF: Development of functional secretory IgA responses (Prof. A. Macpherson, CHF 1’100’000)
  • Bridge – Discovery (Prof. A. Macpherson, CHF 1’561’346)
  • SNF Sinergia: Understanding the role of immunometabolic imprinting for sustainable weight loss (Prof. Z. Al Nabhani CHF 1,261,612)
  • SNF: Role of endothelial CCL22-CCR4 axis due to increased stiffness in chronic liver disease (Prof. A Berzigotti, CHF 763’255)
  • Gilead: SPEARHEAD (Screening imPlEmentation and linkage to cARe inHEpAtitis Delta). (Prof. N. Semmo, Prof. A. Kremer, USZ, CHF 200'000)
  • SNF ERA-NET + EJP Grant: The link between GUT microbiota and MOOD disorders under scrutinY from humans to mice: spotlight on depression: (Prof. Yilmaz, CHF 286'000)
  • Protected Research Time für klinisch tätige Nachwuchsforschende (PRT Grant): Epigenetic Programming of the Intestinal Epithelium by High-Fat-Diet and Microbiota: Implications for Barrier Function (Dr. Jaqueline Wyss)
  • American Crohn’s Colitis Foundation: Impact of early life environmental exposures on adult colitis development (Prof. Z. Al Nabhani, $ 390'000)
  • Kenneth Rainin Foundation (USA): Consequences of early life host-microbial mutualism on inflammatory bowel diseases (Prof. Z. Al Nabhani, $ 150'000, second year)
  • SNSF- JSPS: Enteral oxygenation to rewire mucosal immunity and microbial dynamics (Prof. Z. Al Nabhani, CHF 300'000)
  • Synapsis Foundation: Unravelling the role of pro-inflammatory memory in Alzheimer's disease development (Prof. Z. Al Nabhani, CHF 300'000)

Highlights 2025

«Mausmikrobiom-Atlas» stärkt die Reproduzierbarkeit von Tierversuchen

Yilmaz et al., Cell Host Microbe. 2025